Levetiracetam plus Oxcarbazepine Combination Treatment Downregulates Serum Multidrug Resistance Protein 1 Levels and Upregulates Neuropeptide Y Levels in Children with Epilepsy. Braz. J. Pharm. Sci. [Internet]. 2023 May 8 [cited 2024 May 2];59:e21414. Available from: https://www.revistas.usp.br/bjps/article/view/211884